|
FOI3616 |
|||||||||||||||||||||||||||||||||||||||
|
ECT Questions |
|
||||||||||||||||||||||||||||||||||||||
|
1. Please supply patient’s information ECT leaflet. |
Any use of ECT is carried out outside of this Trust. We do not have copies of leaflets/ forms that are supplied. |
||||||||||||||||||||||||||||||||||||||
|
2. Please supply patient ECT consent form. |
As 1 above |
||||||||||||||||||||||||||||||||||||||
|
3. Please supply any ECT reports/investigations |
Any use of ECT is carried out outside of this Trust. We cannot report information at an individual patient level. |
||||||||||||||||||||||||||||||||||||||
|
4. How many ECT in 2024? |
We have now been advised all ECT questions are to be answered by Leeds Trust. |
||||||||||||||||||||||||||||||||||||||
|
5. What proportion of patients were men/women? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
6. How old were they? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
7. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
8. How many people covered by the equality act received ECT? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
9. How many people were offered talking therapy prior to ECT? |
The information is not held in reportable fields within the patient records but is held in text entries which would have to be reviewed in order to extract the required information |
||||||||||||||||||||||||||||||||||||||
|
10. How many were receiving ECT for the first time? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
11. How many patients consented to ECT? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
12. How many ECT complaints were investigated outside the NHS and CCG? |
Investigations could occur which we are not aware of. |
||||||||||||||||||||||||||||||||||||||
|
13. How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)? |
As 9 above |
||||||||||||||||||||||||||||||||||||||
|
14. How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)? |
As 9 above |
||||||||||||||||||||||||||||||||||||||
|
15. How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)? |
As 9 above |
||||||||||||||||||||||||||||||||||||||
|
16. How many patients have suffered complications during and after ECT and what were those complications? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
17. Have there been any formal complaints from patients/relatives about ECT? |
No complaints have been raised via PACS regarding ECT |
||||||||||||||||||||||||||||||||||||||
|
18. If so, what was their concerns? |
As 17 above |
||||||||||||||||||||||||||||||||||||||
|
19. How many patients report memory loss/loss of cognitive function? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
20. What tests are used to assess memory loss/loss of cognitive function? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
21. Have MRI or CT scans been used before and after ECT? |
As 9 above |
||||||||||||||||||||||||||||||||||||||
|
22. If so, what was the conclusion? |
As 9 above |
||||||||||||||||||||||||||||||||||||||
|
23. How does the Trust plan to prevent ECT in the future? |
There is no plan regarding reduction in ECT, it is only used as last resort or maintenance |
||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||
|
Restraint Questions |
|
||||||||||||||||||||||||||||||||||||||
|
1. Please supply any Restraints/investigations |
2794 |
||||||||||||||||||||||||||||||||||||||
|
2. How many RESTRAINTS in 2024? |
2794 |
||||||||||||||||||||||||||||||||||||||
|
3. What proportion of patients were men/women?
|
|
||||||||||||||||||||||||||||||||||||||
|
4. How old were they?
|
|
||||||||||||||||||||||||||||||||||||||
|
5. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?
|
|
||||||||||||||||||||||||||||||||||||||
|
6. How many people covered by the equality act were restrained? |
All |
||||||||||||||||||||||||||||||||||||||
|
7. How many RESTRAINTS were investigated outside the NHS and CCG? |
Investigations could occur which we are not aware of. |
||||||||||||||||||||||||||||||||||||||
|
8. How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
9. How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
10. How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
11. How many patients have suffered complications during and after RESTRAINTS and what were those complications? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
12. Have there been any formal complaints from patients/relatives about RESTRAINTS? |
5 complaints have been raised via PACS regarding restraint interventions |
||||||||||||||||||||||||||||||||||||||
|
13. If so, what was their concerns? |
SU unhappy was not provided with debrief report following restraint incident |
||||||||||||||||||||||||||||||||||||||
|
14. Are counts of forced injections available? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
15. How does the Trust plan to reduce restraints in the future? |
BDCFT is committed to a no force first approach to managing risk of violence and aggression (be that towards self or others) in all settings. Most commonly regulated restraint is practiced by trained staff after all other steps have been taken in our inpatient services. We routinely monitor use of restrictive practice on a monthly basis in our positive and proactive forum.All staff receive training in trauma informed care and conflict resolution alongside when and how to implement safe holds. The Trust seek to engage people in managing their own behaviour and risk, adopting a formulation based approach. We share examples of good practice from our various units, so people can learn from one another about what works in mediating the need to use of restrictions. Our goals is of course to never need to use restrictions (though this might not be completely realistic). We ensure people have information shared with them about the potential for use of restrictions on admission and in cases where all other approaches have failed we offer people (staff and service users) a debriefing space in the aftermath to reduce the risk of re-traumatisation and to learn proactively about how to reduce the risk of needing such interventions in future which feeds into people’s risk management plans. |
||||||||||||||||||||||||||||||||||||||
|
16.How many of these restraints were face down restraints? |
12 |
||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||
|
Seclusion Questions |
|
||||||||||||||||||||||||||||||||||||||
|
1. Please supply any SECLUSION reports/investigations |
50 |
||||||||||||||||||||||||||||||||||||||
|
2. How many SECLUSIONS in 2024? |
50 |
||||||||||||||||||||||||||||||||||||||
|
3. What proportion of patients were men/women?
|
|
||||||||||||||||||||||||||||||||||||||
|
4. How old were they?
|
|
||||||||||||||||||||||||||||||||||||||
|
5. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?
|
|
||||||||||||||||||||||||||||||||||||||
|
6. How many people covered by the Equality Act were secluded? |
All |
||||||||||||||||||||||||||||||||||||||
|
7. How many SECLUSIONS were investigated outside the NHS and CCG? |
Investigations could occur which we are not aware of. |
||||||||||||||||||||||||||||||||||||||
|
8. How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
9. How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
10. How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
11. How many patients have suffered complications during and after SECLUSION and what were those complications? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
12. Have there been any formal complaints from patients/relatives about SECLUSION? |
2 |
||||||||||||||||||||||||||||||||||||||
|
13. If so, what was their concerns? |
seclusion 6 months due to threatening behaviour. |
||||||||||||||||||||||||||||||||||||||
|
14. How does the Trust plan to prevent SECLUSION in the future? |
BDCFT is committed to a no force first approach to managing risk of violence and aggression (be that towards self or others) in all settings. Most commonly regulated restraint is practiced by trained staff after all other steps have been taken in our inpatient services. We routinely monitor use of restrictive practice on a monthly basis in our positive and proactive forum. All staff receive training in trauma informed care and conflict resolution alongside when and how to implement safe holds. We seek to engage people in managing their own behaviour and risk, adopting a formulation based approach. We share examples of good practice from our various units, so people can learn from one another about what works in mediating the need to use of restrictions. Our goals is of course to never need to use restrictions (though this might not be completely realistic). We ensure people have information shared with them about the potential for use of restrictions on admission and in cases where all other approaches have failed we offer people (staff and service users) a debriefing space in the aftermath to reduce the risk of re-traumatisation and to learn proactively about how to reduce the risk of needing such interventions in future which feeds into people’s risk management plans. |
||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||
|
Medication errors |
|
||||||||||||||||||||||||||||||||||||||
|
1. Please supply any MEDICATION ERRORS reports/investigations |
784 |
||||||||||||||||||||||||||||||||||||||
|
2. How many MEDICATION ERRORS in 2024? |
784 |
||||||||||||||||||||||||||||||||||||||
|
3. What proportion of patients were men/women?
|
|
||||||||||||||||||||||||||||||||||||||
|
4. How old were they?
|
|
||||||||||||||||||||||||||||||||||||||
|
5. What proportion of patients were classified people of the global majority or racialised communities ("POC / BAME")?
|
|
||||||||||||||||||||||||||||||||||||||
|
6. How many people covered by the equality act endured medication errors? |
All |
||||||||||||||||||||||||||||||||||||||
|
7. How many MEDICATION ERRORS were investigated outside the NHS and CCG? |
Investigations could occur which we are not aware of. |
||||||||||||||||||||||||||||||||||||||
|
8. How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
9. How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
10. How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
11. How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications? |
As 3 above |
||||||||||||||||||||||||||||||||||||||
|
12. Have there been any formal complaints from patients/relatives about MEDICATION ERRORS? |
13 |
||||||||||||||||||||||||||||||||||||||
|
13. If so, what was their concerns? |
1. Relative unhappy SU’s prescription had not been handed over to GP, causing delays in accessing medication
told SU was not taking his insulin or lamotrigine whilst an inpatient
administering insulin on time.
prescribed caused kidney failure and hospitalisation
issuing prescribed medication.
had not been taking medication for months due to her care coordinator being on extended unplanned leave (they normally order meds for her and has them delivered)
vaccine without consent.
medication.
regarding SU's prescription as he is often without medication and having a difficult time as the prescription isn't set up on repeat
antibiotic cream. DN said would put prescription through twice but didn’t.
of anxiety medication, thinks a mistake has been made
whilst an inpatient.
management, alleges DNs refused to administer morphine and levo which was prescribed by GP. Led to difficulty breathing, agitation and distress. |
||||||||||||||||||||||||||||||||||||||
|
14. How does the Trust plan to prevent MEDICATION ERRORS in the future? |
All medication errors and near misses which take place are reported on the Trust Incident Report and Risk Register System. Each incident is reviewed and investigated by an allocated manager. After investigation, the manager will close the incident with a list of actions which have resulted from the error/near miss which occurred. The staff involved in the error will complete a reflection where appropriate and further training for the staff may be carried out, if required. All medication incidents are also sent to the medicines safety officer for information.
The Medicines Safety Officer is also part of wider system groups with other organisations to share learning across the region and nationally as needed. |
||||||||||||||||||||||||||||||||||||||